AHA: AI Analysis of Images, Videos Can ID Early Hypertension, Diabetes
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 18, 2024 -- Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes, according to a study presented at the American Heart Association Scientific Sessions 2024, held from Nov. 16 to 18 in Chicago.
Ryoko Uchida, from University of Tokyo, and colleagues developed a machine learning algorithm to analyze skin blood flow and spectral features from photos to noninvasively assess biometric information for health monitoring. The analysis included images from approximately 200 participants' faces and hands, as well as blood pressure readings.
The researchers reported that the algorithm detected hypertension with 94.2 percent alignment with the American Heart Association guidelines for stage 1 hypertension, based on pulse wave features. Among 40 percent who had early hypertension, accuracy rates were 86.2 percent for 30-second data segments and 80.9 percent for 5-second segments. When applying the algorithm to video data, it achieved a 75.3 percent accuracy in detecting diabetes, utilizing blood flow patterns as markers.
"This method may someday allow people to monitor their own health at home and could lead to early detection and treatment of high blood pressure and diabetes in people who avoid medical exams and blood tests," Uchida said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-19 06:00
Read more
- In a National First, an Idaho Health Department Is Refusing to Give COVID Vaccines
- Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
- President-Elect Trump Nominates Robert F. Kennedy Jr. to Lead HHS
- Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
- Camurus Provides Regulatory Update on the US NDA for CAM2029 in Acromegaly
- U.K. Reports First Cluster Outside of Africa of New Mpox Variant
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions